ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Perrigo Expands OTC Growth Strategy with Licensing for Nasonex
americanpharmaceuticalreview
August 10, 2018Perrigo has entered into a licensing agreement with a subsidiary of Merck for the exclusive rights in the United States to pursue regulatory approval for a non-prescription, over-the-counter (OTC) Nasonex (mometasone furoate monohydrate) Nasal Spray.
Pharma Sources Insight July 2025
